Skylark Bio
Cambridge
About Skylark Bio
Skylark Bio is a biotechnology company that develops gene therapies to treat hearing losses. The company was founded in 2021 and is based in Cambridge, Massachusetts, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $40.9M
- Last round: Series Unknown (Aug 2022)
- Website: skylarkbio.com
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/skylark-bio-25014 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.